Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 317 participants.

Also called NCT04436822

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 317 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04436822
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04436822. Allocation not applicable; no masking; primary purpose other. Start 2020-07-15 (actual); primary completion 2022-04-12 (actual). Results posted on 2023-06-02.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics
Condition
Type 1 Diabetes Mellitus
Condition
Type 2 Diabetes Mellitus
Intervention (Device)
Continuous Glucose Monitoring
Lead sponsor
Medtronic MiniMed, Inc. (class: industry)

Record details

Record id
cardio:ct-nct04436822
Content hash
b4ba9e247ac1a822fe39eecbeb40841df30bc39945baace782a68475e537c041